Top 10 most viewed pages
Which offers are attracting investors’ interest?
Every Monday we look at the offers and articles that Wealth Club members have viewed on our website the previous week. Then we compile the top ten across the different types of investment: VCTs, EIS, SEIS, IHT portfolios, AIM IHT ISAs and Alternatives.
Below are the top ten most viewed offers and articles last week. Go to each page to read our reviews, download documents and apply online.
Please note: this list is not advice nor a personal recommendation to invest. It is provided for information, based on Wealth Club members' use of our website, and you should make your own considered view on the merit of each offer. Remember, these kind of investments are for experienced investors only. Before investing, please read all the offer documents to ensure you understand the benefits, risks and charges. If you’re unsure, please seek advice.
Last week’s top 10 most viewed offers
| Week of 23 to 29 March 2020 | Compared to previous week | |
|---|---|---|
| 1 | Article: VCTs – are you investing at yesterday's prices? | — |
| 2 | Article: VCTs fundraising update | NEW ENTRY |
| 3 | Article: Coronavirus – an update from Octopus Titan VCT | ⬇ |
| 4 | Our choice Octopus Titan VCT | ⬇ |
| 5 | Our choice Octopus AIM IHT ISA | ⬆ |
| 6 | Article: Coronavirus – an update from Octopus AIM Inheritance Tax Service | NEW ENTRY |
| 7 | Our choice Northern VCTs | ⬇ |
| 8 | Article: Coronavirus: impact on AIM market and AIM fund manager reactions | NEW ENTRY |
| 9 | Our choice Unicorn AIM VCT | ⬇ |
| 10 | Article: EIS and SEIS aiming to allot shares this tax year | ⬇ |
Wealth Club aims to make it easier for experienced investors to find information on – and apply for – tax-efficient investments. You should base your investment decision on the provider's documents and ensure you have read and fully understand them before investing. This review is a marketing communication. It is not advice or a personal or research recommendation to buy the investment mentioned. It does not satisfy legal requirements promoting investment research independence and is thus not subject to prohibitions on dealing ahead of its dissemination.